Literature DB >> 26846219

Endocrine dysregulation in women with irritable bowel syndrome according to Rome II criteria.

Charlotte Markert1, Kerstin Suarez-Hitz2, Ulrike Ehlert2, Urs M Nater3.   

Abstract

The etiology of the irritable bowel syndrome (IBS) is unexplained: biological, psychological and social factors must be considered. This study examined if differences in HPA-axis activity already exist in those who do not yet fulfill IBS criteria (i.e. "subthreshold IBS"). We also investigated whether there were differences between those who reported clinically relevant (i.e. distressing) IBS symptoms and those who did not. Thirty-six women were subdivided into three groups (IBS group, subthreshold IBS group, control group). Results showed differences in morning cortisol levels (U = 11.58; p < 0.05), with IBS patients showing a lower cortisol response compared to controls. Subthreshold IBS patients were comparable to controls regarding endocrine function. Diurnal cortisol levels did not differ between groups. Group comparisons between distressed subjects and non-distressed subjects regarding cortisol levels did not reach significance. The finding of endocrine abnormalities (at least in a sub-set of patients) is important since these might be associated with deficient pain processing in IBS.

Entities:  

Keywords:  Cortisol awakening response; Distress; Irritable bowel syndrome; Rome II criteria; Rome III criteria

Mesh:

Substances:

Year:  2016        PMID: 26846219     DOI: 10.1007/s10865-016-9718-x

Source DB:  PubMed          Journal:  J Behav Med        ISSN: 0160-7715


  41 in total

Review 1.  The neurobiology of stress and gastrointestinal disease.

Authors:  E A Mayer
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

2.  Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study.

Authors:  Smita L S Halder; G Richard Locke; Cathy D Schleck; Alan R Zinsmeister; L Joseph Melton; Nicholas J Talley
Journal:  Gastroenterology       Date:  2007-06-20       Impact factor: 22.682

3.  Salivary cortisol in a middle-aged community sample: results from 990 men and women of the KORA-F3 Augsburg study.

Authors:  Florian Lederbogen; Christine Kühner; Clemens Kirschbaum; Christa Meisinger; Josefine Lammich; Rolf Holle; Bertram Krumm; Thomas von Lengerke; Heinz-Erich Wichmann; Michael Deuschle; Karl-Heinz Ladwig
Journal:  Eur J Endocrinol       Date:  2010-06-24       Impact factor: 6.664

4.  Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population.

Authors:  F Mearin; X Badía; A Balboa; E Baró; E Caldwell; M Cucala; M Díaz-Rubio; A Fueyo; J Ponce; M Roset; N J Talley
Journal:  Scand J Gastroenterol       Date:  2001-11       Impact factor: 2.423

5.  Basal and stimulated hypothalamic-pituitary-adrenal axis activity in patients with functional gastrointestinal disorders and healthy controls.

Authors:  Andreas H Böhmelt; Urs M Nater; Saskia Franke; Dirk H Hellhammer; Ulrike Ehlert
Journal:  Psychosom Med       Date:  2005 Mar-Apr       Impact factor: 4.312

6.  High and low unstimulated salivary cortisol levels correspond to different symptoms of functional gastrointestinal disorders.

Authors:  Ulrike Ehlert; Urs M Nater; Andreas Böhmelt
Journal:  J Psychosom Res       Date:  2005-07       Impact factor: 3.006

7.  Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress.

Authors:  I Posserud; P Agerforz; R Ekman; E S Björnsson; H Abrahamsson; M Simrén
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

8.  Psychological coping styles and cortisol over the day in healthy older adults.

Authors:  Katie O'Donnell; Ellena Badrick; Meena Kumari; Andrew Steptoe
Journal:  Psychoneuroendocrinology       Date:  2008-03-07       Impact factor: 4.905

9.  Several daily measurements are necessary to reliably assess the cortisol rise after awakening: state- and trait components.

Authors:  J Hellhammer; E Fries; O W Schweisthal; W Schlotz; A A Stone; D Hagemann
Journal:  Psychoneuroendocrinology       Date:  2006-11-28       Impact factor: 4.905

10.  Psychosocial risk markers for new onset irritable bowel syndrome--results of a large prospective population-based study.

Authors:  B I Nicholl; S L Halder; G J Macfarlane; D G Thompson; S O'Brien; M Musleh; J McBeth
Journal:  Pain       Date:  2007-10-10       Impact factor: 6.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.